For most people, the common cold is something that can be quickly recovered from. For the over 1 million people in the UK who are living with COPD, the common cold can lead to flare-ups of COPD symptoms. This research study hopes to help those people…
This study is investigating the effectiveness of the study treatment at reducing the severity / duration of respiratory symptoms associated with the common cold in patients with COPD.
Are you currently living with COPD? This study could be for you…
This study is open to anyone who:
- Is between the ages of 40 and 85
- Has a confirmed diagnosis of COPD
- Has a history of COPD exacerbations within the past year.
(An exacerbation is any flare up of COPD that has required any increased use of medications or required steroids or hospitalisation.)
Other inclusion / exclusion criteria will apply and this will be discussed with you by one of our research team over the phone
Your participation in this study will last for up to 18 months and will involve taking the study treatment, or a placebo, once a day for 7 days during a time period when you have the cold. This study is placebo-controlled meaning half of the participants will receive the study treatment and the other half will receive a placebo.
Your participation will also involve visits to our clinic throughout the course of the study.
You will receive compensation for your study related time and activities, such as visits to our clinic
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
